Amgen : AMGN

All Amgen Articles

699 Articles

Douglas A. McIntyre | Sep 21, 2009 at 9:14 AM EDT

Top Day Trader Alerts (DPTR, AMGN, PER, DELL, LEN, POT, MOS)

These are this Monday’s top day trader and active trader alert stocks in the pre-market. We have more details on…

Douglas A. McIntyre | Aug 24, 2009 at 9:54 AM EDT

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the…

Douglas A. McIntyre | Aug 14, 2009 at 7:51 AM EDT

Top 10 Analyst Upgrades and Downgrades (AMGN, AVY, COLM, DSGX, EJ, JASO, KG, SCSS, SPWRA, THC)

These are the ten top analyst upgrades,downgrades, and initiations we have seen early this Friday morning with roughly two hours…

Douglas A. McIntyre | Aug 11, 2009 at 7:58 AM EDT

Top 10 Analyst Upgrades/Downgrades (AMGN, CELL, ELON, SATS, KR, QLGC, MBI, PETM, S, YUM)

These are the top 10 pre-market analyst upgrades and downgrades in Wall Street research calls this Tuesday morning: Amgen (AMGN)…

Douglas A. McIntyre | Jul 28, 2009 at 8:57 AM EDT

Top Day Trader Alerts (SPSS, X, VICL, AMGN, ARIA, LCRD, DB, COH, CHKP)

The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume…

Douglas A. McIntyre | Jul 28, 2009 at 3:49 AM EDT

Media Digest 7/28/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Reuters: The recession has badly hurt investments in green technologies. Reuters: Obama called for deeper China ties with the US.…

Douglas A. McIntyre | Jul 23, 2009 at 9:12 AM EDT

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jul 8, 2009 at 9:47 AM EDT

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details…

Douglas A. McIntyre | Jul 8, 2009 at 8:10 AM EDT

Day Trader Alerts (AMGN, NVS, MSCS, DRYS, ARYX, XNPT, ARNA, BPZ)

These are some of the top stocks for day traders and active traders to watch based on pre-market and after-hours…

Douglas A. McIntyre | Jun 25, 2009 at 11:31 AM EDT

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early…

Douglas A. McIntyre | May 27, 2009 at 1:34 PM EDT

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data…

Douglas A. McIntyre | May 6, 2009 at 6:26 AM EDT

Top Analyst Upgrades (ALU, AMGN, HBC, IFX, SMTC, DIS, WBMD)

These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street this…

Douglas A. McIntyre | Apr 24, 2009 at 6:30 AM EDT

Top Analyst Upgrades & Downgrades (AMGN, CS, BEAT, DV, MAR, MSFT, RIMM, SPWRA, TOL)

These are among the top research calls and analyst upgrades and downgrades we have seen early this Friday morning with…

Douglas A. McIntyre | Apr 23, 2009 at 3:27 PM EDT

Amgen Back To Doldrums (AMGN)

Amgen Inc. (NASDAQ: AMGN) has posted some very highly anticipated and uninteresting earnings. The biotech giant reported $0.98 EPS net…

1 … 40 41 42 43 44 … 47

Amgen : AMGN

All Amgen Articles

Top Day Trader Alerts (DPTR, AMGN, PER, DELL, LEN, POT, MOS)

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Top 10 Analyst Upgrades and Downgrades (AMGN, AVY, COLM, DSGX, EJ, JASO, KG, SCSS, SPWRA, THC)

Top 10 Analyst Upgrades/Downgrades (AMGN, CELL, ELON, SATS, KR, QLGC, MBI, PETM, S, YUM)

Top Day Trader Alerts (SPSS, X, VICL, AMGN, ARIA, LCRD, DB, COH, CHKP)

Media Digest 7/28/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

The Next Blockbuster Drugs: A $170 Billion Opportunity

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

Day Trader Alerts (AMGN, NVS, MSCS, DRYS, ARYX, XNPT, ARNA, BPZ)

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Top Analyst Upgrades (ALU, AMGN, HBC, IFX, SMTC, DIS, WBMD)

Top Analyst Upgrades & Downgrades (AMGN, CS, BEAT, DV, MAR, MSFT, RIMM, SPWRA, TOL)

Amgen Back To Doldrums (AMGN)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amgen : AMGN

All Amgen Articles

Top Day Trader Alerts (DPTR, AMGN, PER, DELL, LEN, POT, MOS)

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Top 10 Analyst Upgrades and Downgrades (AMGN, AVY, COLM, DSGX, EJ, JASO, KG, SCSS, SPWRA, THC)

Top 10 Analyst Upgrades/Downgrades (AMGN, CELL, ELON, SATS, KR, QLGC, MBI, PETM, S, YUM)

Top Day Trader Alerts (SPSS, X, VICL, AMGN, ARIA, LCRD, DB, COH, CHKP)

Media Digest 7/28/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

The Next Blockbuster Drugs: A $170 Billion Opportunity

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

Day Trader Alerts (AMGN, NVS, MSCS, DRYS, ARYX, XNPT, ARNA, BPZ)

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Top Analyst Upgrades (ALU, AMGN, HBC, IFX, SMTC, DIS, WBMD)

Top Analyst Upgrades & Downgrades (AMGN, CS, BEAT, DV, MAR, MSFT, RIMM, SPWRA, TOL)

Amgen Back To Doldrums (AMGN)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s